170 related articles for article (PubMed ID: 36453734)
1. Rare cause of life-threatening hypercalcemia in an infant: a case report.
Lefèvre CR; Peltier L; Lokchine A; Ryckewaert A; Moreau C
Ann Biol Clin (Paris); 2022 Sep; 80(5):460-463. PubMed ID: 36453734
[TBL] [Abstract][Full Text] [Related]
2. CYP24A1 and SLC34A1 Pathogenic Variants Are Uncommon in a Canadian Cohort of Children with Hypercalcemia or Hypercalciuria.
Rousseau-Nepton I; Jones G; Schlingmann K; Kaufmann M; Zuijdwijk CS; Khatchadourian K; Gupta IR; Pacaud D; Pinsk MN; Mokashi A; Nour MA; Alexander RT; Rodd CJ
Horm Res Paediatr; 2021; 94(3-4):124-132. PubMed ID: 34320495
[TBL] [Abstract][Full Text] [Related]
3. Kidney function and influence of sunlight exposure in patients with impaired 24-hydroxylation of vitamin D due to CYP24A1 mutations.
Figueres ML; Linglart A; Bienaime F; Allain-Launay E; Roussey-Kessler G; Ryckewaert A; Kottler ML; Hourmant M
Am J Kidney Dis; 2015 Jan; 65(1):122-6. PubMed ID: 25446019
[TBL] [Abstract][Full Text] [Related]
4. Overlapping Phenotypes Associated With
Molin A; Lemoine S; Kaufmann M; Breton P; Nowoczyn M; Ballandonne C; Coudray N; Mittre H; Richard N; Ryckwaert A; Lavillaureix A; Jones G; Bacchetta J; Kottler ML
Front Endocrinol (Lausanne); 2021; 12():736240. PubMed ID: 34721296
[TBL] [Abstract][Full Text] [Related]
5. Molecular characterization of a recurrent 10.9 kb CYP24A1 deletion in Idiopathic Infantile Hypercalcemia.
Molin A; Nowoczyn M; Coudray N; Ballandone C; Abéguilé G; Mittre H; Richard N; Eckart P; Castanet M; Kottler ML
Eur J Med Genet; 2019 Nov; 62(11):103577. PubMed ID: 30423445
[TBL] [Abstract][Full Text] [Related]
6. Analysis of vitamin D
Kowalska E; Rola R; Wójcik M; Łaszcz N; Płudowski P; Wierzbicka A; Janiec A; Książyk J; Halat P; Ciara E; Obrycki Ł; Pronicka E; Litwin M
J Steroid Biochem Mol Biol; 2021 Apr; 208():105824. PubMed ID: 33516786
[TBL] [Abstract][Full Text] [Related]
7. Do the Heterozygous Carriers of a CYP24A1 Mutation Display a Different Biochemical Phenotype Than Wild Types?
Brancatella A; Cappellani D; Kaufmann M; Borsari S; Piaggi P; Baldinotti F; Caligo MA; Jones G; Marcocci C; Cetani F
J Clin Endocrinol Metab; 2021 Mar; 106(3):708-717. PubMed ID: 33249478
[TBL] [Abstract][Full Text] [Related]
8. [New Mutation of CYP24A1 in a Case of Idiopathic Infantile Hypercalcemia Diagnosed in Adulthood].
Zanchelli F; Giudicissi A; Neri L; Sgarlato V; Bruno PF; Ruggeri M; Signorotti S; Vetrano D; Buscaroli A
G Ital Nefrol; 2023 Dec; 40(6):. PubMed ID: 38156538
[TBL] [Abstract][Full Text] [Related]
9. CYP24A1 Mutations in a Cohort of Hypercalcemic Patients: Evidence for a Recessive Trait.
Molin A; Baudoin R; Kaufmann M; Souberbielle JC; Ryckewaert A; Vantyghem MC; Eckart P; Bacchetta J; Deschenes G; Kesler-Roussey G; Coudray N; Richard N; Wraich M; Bonafiglia Q; Tiulpakov A; Jones G; Kottler ML
J Clin Endocrinol Metab; 2015 Oct; 100(10):E1343-52. PubMed ID: 26214117
[TBL] [Abstract][Full Text] [Related]
10. CYP24A1 loss of function: Clinical phenotype of monoallelic and biallelic mutations.
Carpenter TO
J Steroid Biochem Mol Biol; 2017 Oct; 173():337-340. PubMed ID: 28093352
[TBL] [Abstract][Full Text] [Related]
11. Idiopathic infantile hypercalcemia: mutations in SLC34A1 and CYP24A1 in two siblings and fathers.
Güven A; Konrad M; Schlingmann KP
J Pediatr Endocrinol Metab; 2020 Aug; 33(10):1353-1358. PubMed ID: 32866123
[TBL] [Abstract][Full Text] [Related]
12. 1,25-(OH)2D-24 Hydroxylase (CYP24A1) Deficiency as a Cause of Nephrolithiasis.
Nesterova G; Malicdan MC; Yasuda K; Sakaki T; Vilboux T; Ciccone C; Horst R; Huang Y; Golas G; Introne W; Huizing M; Adams D; Boerkoel CF; Collins MT; Gahl WA
Clin J Am Soc Nephrol; 2013 Apr; 8(4):649-57. PubMed ID: 23293122
[TBL] [Abstract][Full Text] [Related]
13. Loss-of-function mutations of CYP24A1, the vitamin D 24-hydroxylase gene, cause long-standing hypercalciuric nephrolithiasis and nephrocalcinosis.
Dinour D; Beckerman P; Ganon L; Tordjman K; Eisenstein Z; Holtzman EJ
J Urol; 2013 Aug; 190(2):552-7. PubMed ID: 23470222
[TBL] [Abstract][Full Text] [Related]
14. AN INFANT WITH IDIOPATHIC HYPERCALCIURIA AND NEPHROLITHIASIS ASSOCIATED WITH CYP24A1 ENZYME POLYMORPHISM: A CASE REPORT.
Trutin I; Škorić I
Acta Clin Croat; 2022 Feb; 60(3):544-547. PubMed ID: 35282483
[TBL] [Abstract][Full Text] [Related]
15. A rapid screening of a recurrent CYP24A1 pathogenic variant opens the way to molecular testing for Idiopathic Infantile Hypercalcemia (IIH).
De Paolis E; Minucci A; De Bonis M; Scaglione GL; Gervasoni J; Primiano A; Ferraro PM; Cappellani D; Marcocci C; Gambaro G; Capoluongo E
Clin Chim Acta; 2018 Jul; 482():8-13. PubMed ID: 29574006
[TBL] [Abstract][Full Text] [Related]
16. Vitamin D-Mediated Hypercalcemia: Mechanisms, Diagnosis, and Treatment.
Tebben PJ; Singh RJ; Kumar R
Endocr Rev; 2016 Oct; 37(5):521-547. PubMed ID: 27588937
[TBL] [Abstract][Full Text] [Related]
17. Idiopathic Infantile Hypercalcemia, Presenting in Adulthood--No Longer Idiopathic Nor Infantile: Two Case Reports and Review.
Tray KA; Laut J; Saidi A
Conn Med; 2015; 79(10):593-7. PubMed ID: 26731879
[TBL] [Abstract][Full Text] [Related]
18. CYP3A4 Induction by Rifampin: An Alternative Pathway for Vitamin D Inactivation in Patients With CYP24A1 Mutations.
Hawkes CP; Li D; Hakonarson H; Meyers KE; Thummel KE; Levine MA
J Clin Endocrinol Metab; 2017 May; 102(5):1440-1446. PubMed ID: 28324001
[TBL] [Abstract][Full Text] [Related]
19. Biallelic and monoallelic pathogenic variants in CYP24A1 and SLC34A1 genes cause idiopathic infantile hypercalcemia.
Wang Q; Chen JJ; Wei LY; Ding Y; Liu M; Li WJ; Su C; Gong CX
Orphanet J Rare Dis; 2024 Mar; 19(1):126. PubMed ID: 38504242
[TBL] [Abstract][Full Text] [Related]
20. [A young girl with recurrent calculosis and hypercalcemia].
Di Maio F; Vittori M; Bassi P; Fulignati P; D'Alonzo S; Ferraro PM
G Ital Nefrol; 2018 May; 35(3):. PubMed ID: 29786188
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]